Matthew Taylor
Stock Analyst at Jefferies
(3.37)
# 1,003
Out of 5,109 analysts
183
Total ratings
61.26%
Success rate
11.1%
Average return
Main Sectors:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $105 | $83.39 | +25.91% | 3 | Dec 11, 2025 | |
| PODD Insulet | Maintains: Neutral | $320 → $355 | $288.82 | +22.91% | 16 | Nov 7, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $80 → $98 | $86.29 | +13.57% | 20 | Oct 29, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $19 | $15.29 | +24.26% | 1 | Aug 25, 2025 | |
| ABT Abbott Laboratories | Upgrades: Buy | $143 → $145 | $124.81 | +16.18% | 17 | Jul 18, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $14.47 | +3.66% | 7 | Apr 14, 2025 | |
| MDT Medtronic | Maintains: Sell | $75 → $76 | $97.27 | -21.87% | 17 | May 24, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $125 | $1.39 | +8,892.81% | 1 | Feb 9, 2024 | |
| MASI Masimo | Downgrades: Hold | $107 → $121 | $133.28 | -9.21% | 9 | Jan 30, 2024 | |
| OBIO Orchestra BioMed Holdings | Initiates: Buy | $14 | $4.31 | +225.20% | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $45 | $22.48 | +100.18% | 2 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $10 | $6.05 | +65.29% | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $53 | $12.66 | +318.64% | 2 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $22 → $24 | $12.16 | +97.37% | 2 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $345 | $354.74 | -2.75% | 14 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $115 → $130 | $90.23 | +44.08% | 8 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $230 | $315.86 | -27.18% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $20.37 | -1.82% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $40.17 | +111.60% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $88.43 | -15.19% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $245 | $244.44 | +0.23% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $62 | $19.11 | +224.44% | 8 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $122.33 | +71.67% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $20.77 | -42.21% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $67.42 | +85.40% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $96.13 | -47.99% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $577.15 | -63.61% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $96 | $63.14 | +52.04% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $3.95 | +77.22% | 1 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $266 | $196.12 | +35.63% | 4 | May 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $16 | $13.17 | +21.49% | 2 | Jul 19, 2017 |
GE HealthCare Technologies
Dec 11, 2025
Maintains: Buy
Price Target: $95 → $105
Current: $83.39
Upside: +25.91%
Insulet
Nov 7, 2025
Maintains: Neutral
Price Target: $320 → $355
Current: $288.82
Upside: +22.91%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Buy
Price Target: $80 → $98
Current: $86.29
Upside: +13.57%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $19
Current: $15.29
Upside: +24.26%
Abbott Laboratories
Jul 18, 2025
Upgrades: Buy
Price Target: $143 → $145
Current: $124.81
Upside: +16.18%
InMode
Apr 14, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $14.47
Upside: +3.66%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75 → $76
Current: $97.27
Upside: -21.87%
Allurion Technologies
Feb 9, 2024
Initiates: Buy
Price Target: $125
Current: $1.39
Upside: +8,892.81%
Masimo
Jan 30, 2024
Downgrades: Hold
Price Target: $107 → $121
Current: $133.28
Upside: -9.21%
Orchestra BioMed Holdings
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $4.31
Upside: +225.20%
Oct 2, 2023
Maintains: Buy
Price Target: $47 → $45
Current: $22.48
Upside: +100.18%
Jul 19, 2023
Initiates: Underperform
Price Target: $10
Current: $6.05
Upside: +65.29%
Jul 12, 2023
Upgrades: Buy
Price Target: $58 → $53
Current: $12.66
Upside: +318.64%
May 24, 2023
Maintains: Hold
Price Target: $22 → $24
Current: $12.16
Upside: +97.37%
May 2, 2023
Maintains: Buy
Price Target: $320 → $345
Current: $354.74
Upside: -2.75%
Mar 31, 2023
Upgrades: Hold
Price Target: $115 → $130
Current: $90.23
Upside: +44.08%
Oct 12, 2022
Initiates: Buy
Price Target: $230
Current: $315.86
Upside: -27.18%
Oct 12, 2022
Initiates: Buy
Price Target: $20
Current: $20.37
Upside: -1.82%
Oct 12, 2022
Initiates: Hold
Price Target: $85
Current: $40.17
Upside: +111.60%
Oct 12, 2022
Initiates: Buy
Price Target: $75
Current: $88.43
Upside: -15.19%
Oct 12, 2022
Initiates: Hold
Price Target: $245
Current: $244.44
Upside: +0.23%
Oct 12, 2022
Initiates: Hold
Price Target: $62
Current: $19.11
Upside: +224.44%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $122.33
Upside: +71.67%
Oct 12, 2022
Initiates: Buy
Price Target: $12
Current: $20.77
Upside: -42.21%
Oct 12, 2022
Initiates: Buy
Price Target: $125
Current: $67.42
Upside: +85.40%
Oct 12, 2022
Initiates: Buy
Price Target: $50
Current: $96.13
Upside: -47.99%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $577.15
Upside: -63.61%
Feb 24, 2022
Upgrades: Buy
Price Target: $96
Current: $63.14
Upside: +52.04%
Dec 17, 2021
Initiates: Neutral
Price Target: $7
Current: $3.95
Upside: +77.22%
May 13, 2019
Upgrades: Overweight
Price Target: $266
Current: $196.12
Upside: +35.63%
Jul 19, 2017
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $13.17
Upside: +21.49%